Novavax COVID-19 vaccine review is “incredibly complex” - FDA - Seeking Alpha
4/20/2022 12:00:00 AM3 yearsago
by Dulan Lokuwithana
by Dulan Lokuwithana
A top vaccine official at the U.S. Food and Drug Administration ((FDA)) said on Wednesday that the review of Novavax (NVAX) COVID-19 shot has become “incredibly complex” and the...
Grandbrothers/iStock Editorial via Getty Images A top vaccine official at the U.S. Food and Drug Administration (FDA) said on Wednesday that the review of the Novavax (NASDAQ:NVAX) COVID-19 shot was… [+1272 chars]
full article...